This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

PrEPared and Strong: Clinic-Based PrEP for Black MSM (P&S)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Institute of Mental Health (NIMH)
Gilead Sciences
Information provided by (Responsible Party):
Paul Colson, Columbia University
ClinicalTrials.gov Identifier:
NCT02167386
First received: June 12, 2014
Last updated: April 3, 2017
Last verified: April 2017
  Purpose
Black men who have sex with men (MSM) have among the highest rates of new HIV infections of any group in the United States. Developing effective HIV prevention interventions that work with this group is a critical element of the National HIV/AIDS Strategy. In the first phase of our study ("the ethnographic phase"), the investigators will carry out community-based research that will explore structural, social and cultural factors relevant to how Black MSM might engage with Pre-Exposure Prophylaxis (PrEP). This phase of community-based research will inform the design of an enhanced PrEP adherence intervention, which will be subsequently tested at a community-based health clinic in Harlem in the second phase of the project.

Condition Intervention Phase
HIV/AIDS Behavioral: Enhanced PrEP Adherence Behavioral: Standard PrEP Adherence Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
combination drug and behavioral intervention
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: PrEP for Black MSM: Community-Based Ethnography and Clinic-Based Treatment

Resource links provided by NLM:


Further study details as provided by Paul Colson, Columbia University:

Primary Outcome Measures:
  • adherence to daily Truvada use [ Time Frame: twelve months after enrollment ]
    this is a measure of PrEP adherence, to be implemented through self-reported adherence and collection of dried blood spots


Secondary Outcome Measures:
  • percentage of sexual acts where condom was used [ Time Frame: twelve months after enrollment ]
    this is one measure of sexual risk behaviors. Other such measures include number and type of sexual partner, specific sexual acts, drug/alcohol use during sex, transactional sex

  • number of correct knowledge items [ Time Frame: twelve months after enrollment ]
    this is one outcome measure from a knowledge, attitudes, and practices (KAP) questionnaire related to HIV prevention in general and PrEP in particular

  • number of participants remaining in care [ Time Frame: end of 12-month study period ]
    this is a measure of retention in care. As each participants finishes his 12-month study period, retention will be determined by number of care visits completed.

  • positive HIV test [ Time Frame: during 12-month study period ]
    this is a measure of seroconversion. Participants who test HIV-positive at any quarterly care visit will exit the study and will be referred for HIV care.


Enrollment: 204
Actual Study Start Date: March 30, 2015
Estimated Study Completion Date: July 2018
Estimated Primary Completion Date: February 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Enhanced PrEP Adherence
Enhanced PrEP Adherence: peer navigators, PrEP support group, on-line support group, text message reminders
Behavioral: Enhanced PrEP Adherence
Active Comparator: Standard PrEP Adherence
Standard PrEP Adherence: support groups, case management
Behavioral: Standard PrEP Adherence

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • male at birth
  • self-identify as Black, African American, Caribbean Black, African, or multiethnic Black
  • are 18 years of age or older
  • any male or transgender woman (TGW) partners in past 6 months;
  • not in a monogamous partnership with a recently tested, HIV-negative man;
  • have at least one of the following:
  • reporting condomless anal and/or receptive neovaginal intercourse with at least one man or TGW in the past six months;
  • any STI diagnosed or reported in past 6 months;
  • is in on-going sexual relationship with an HIV-positive male or TGW partner;
  • able to provide written informed consent in English;
  • able to provide a street address or residence or phone number for themselves or two personal contacts who would know their whereabouts during participation in the study

Exclusion Criteria:

  • current participation in any other PrEP study;
  • having taken PrEP in programmatic context more than 3 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02167386

Locations
United States, New York
Harlem Prevention Center
New York, New York, United States, 10027
Harlem United
New York, New York, United States, 10027
Sponsors and Collaborators
Columbia University
National Institute of Mental Health (NIMH)
Gilead Sciences
Investigators
Principal Investigator: Paul W Colson, PhD ICAP, Mailman School of Public Health, Columbia University
  More Information

Responsible Party: Paul Colson, Associate Research Scientist, Columbia University
ClinicalTrials.gov Identifier: NCT02167386     History of Changes
Other Study ID Numbers: AAAO0852
5R01MH098723 ( U.S. NIH Grant/Contract )
Study First Received: June 12, 2014
Last Updated: April 3, 2017

Keywords provided by Paul Colson, Columbia University:
Men who have sex with men (MSM)
Black/African-American

ClinicalTrials.gov processed this record on August 22, 2017